In the ongoing skirmish between India’s drug and device manufacturers and price regulator, the latter has a new commander: Rakesh Kumar Vats, who was handed the additional charge of the chairman of the National Pharmaceutical Pricing Authority (NPPA) in April. Vats takes over at a particularly tense time — the industry was at loggerheads with his predecessor Bhupendra Singh,
Read the full article now
Become a member
Insight-rich storytelling you won't find elsewhere by the finest team of business writers
Great conversations among an elite community of opinion leaders
A great reading experience across all your devices
Exclusive access to members-only events
condoms (manufactured by HLL Lifecare) listed on 1mg.com as on May 1, 2018 An NPPA expert panel has since recommended creating a new category for ‘exotic’ condoms that have additional features compared with ‘utility’ condoms. But according to reports, the industry isn’t thrilled and wants price caps on exotic condoms to go altogether. Will they have the business leader-turned-regulator’s sympathy?